In response to the spread of the mysterious virus from Wuhan, several biotech companies say they are working on a vaccine.
Through Le Figaro with AFP
Biotech company stocks jumped on Wall Street this week as a deadly new virus spread to China, where authorities have confined entire cities.
The Novavax laboratory, for example, jumped 11.42% around 4:00 p.m. GMT on the New York Stock Exchange after announcing that it had “initiated the development of a vaccineAgainst the new coronavirus, which can be transmitted from human to human and which has already killed 17 people. The group has previously researched Middle East Respiratory Syndrome (SEA), Severe Acute Respiratory Syndrome (SARS) and developed a vaccine against the H7N9 flu.
NanoViricides, which works on treatments against various viruses such as avian flu or Ebola, flew on its side Thursday by 36.91%. The value of its title had more than doubled on the stock market Tuesday before collapsing Wednesday after the announcement of the issue of additional shares expected to bring the company $ 7.5 million but also diluting the value of each title .
Moderna, which said it works with US health officials “on a potential vaccine response to the current health emergency“, Took 6.5% in two sessions and appreciated again Thursday by 1.37%.
Inovio was up 6.68% after receiving a $ 9 million grant from the Coalition for Innovations to Prepare for Epidemics (CEPI, Coalition for Epidemic Preparedness Innovations), an organization set up the day after the Ebola epidemic in 2017. Biotech had already received $ 56 million from this organization for research on the Sea.
See also – Three questions about the Chinese virus that worries the world
— .
